Home » Topics » BioWorld Science

BioWorld Science
RSS

Impact Biomedical announces development of Quantum antihistamine

July 27, 2022

Discovery of novel candidates for the treatment of Chagas disease

July 27, 2022

ScinnoHub Pharmaceutical discovers plasmin inhibitors

July 27, 2022

CFB inhibitors identified by Shanghai Hengrui Pharmaceutical, Jiangsu Hengrui Medicine

July 27, 2022

Nonessential but critical, tyrosine plays key role in nutrient sensing

July 26, 2022

New compound advances anoctamin-1 inhibition for analgesia

July 26, 2022

RNF31 as a novel therapeutic target for immunotherapy-refractory cancers

July 26, 2022

Oryzon collaborates with CMTRF to evaluate HDAC6 inhibitors for Charcot-Marie-Tooth disease

July 26, 2022

PsychoGenics to evaluate preclinical antiseizure efficacy of IAMA's selective NKCC1 inhibitors

July 26, 2022

Altamira Therapeutics to develop OligoPhore-based AM-411 for rheumatoid arthritis

July 26, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...